{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31467573", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "07", "Day": "30"}], "Language": ["eng"], "ELocationID": ["2745453", "10.1155/2019/2745453"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2019", "PubDate": {"Year": "2019"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Attenuation Effects of Alpha-Pinene Inhalation on Mice with Dizocilpine-Induced Psychiatric-Like Behaviour.", "Pagination": {"StartPage": "2745453", "MedlinePgn": "2745453"}, "Abstract": {"AbstractText": ["<i>\u03b1</i>-Pinene, an organic terpene compound found in coniferous trees, is used as a safe food additive and is contained in many essential oils. Moreover, some studies have shown that <i>\u03b1</i>-pinene suppresses neuronal activity. In this study, we investigated whether inhalation of <i>\u03b1</i>-pinene suppresses dizocilpine (MK-801-) induced schizophrenia-like behavioural abnormalities in mice. Mice inhaled <i>\u03b1</i>-pinene 1 h before the first MK-801 injection. Thirty minutes after MK-801 injection, the open field, spontaneous locomotor activity, elevated plus maze, Y-maze, tail suspension, hot plate, and grip strength tests were conducted as behavioural experiments. Inhalation of <i>\u03b1</i>-pinene suppressed the activity of mice in the spontaneous locomotor activity test and although it did not suppress the MK-801-induced increased locomotor activity in the open field test, it remarkably decreased the time that the mice remained in the central area. Inhalation of <i>\u03b1</i>-pinene suppressed the MK-801-induced increased total distance travelled in the Y-maze test, whereas it did not alter the MK-801-induced reduced threshold of antinociception in the hot plate test. In the tail suspension and grip strength tests, there was no effect on mouse behaviour by administration of MK-801 and inhalation of <i>\u03b1</i>-pinene. These results suggest that <i>\u03b1</i>-pinene acts to reduce MK-801-induced behavioural abnormalities resembling those seen in neuropsychiatric disorders. Therefore, both medicinal plants and essential oils containing <i>\u03b1</i>-pinene may have potential for therapeutic treatment of schizophrenia."]}, "AuthorList": [{"Identifier": ["0000-0003-0360-5761"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Technology, Kawasaki University of Medical Welfare, Okayama, 701-0193, Japan."}], "LastName": "Ueno", "ForeName": "Hiroshi", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Food and Nutrition, Nakamura Gakuen University Junior College, Fukuoka, 814-0198, Japan."}], "LastName": "Shimada", "ForeName": "Atsumi", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychiatry, Kawasaki Medical School, Kurashiki, 701-0192, Japan."}], "LastName": "Suemitsu", "ForeName": "Shunsuke", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychiatry, Kawasaki Medical School, Kurashiki, 701-0192, Japan."}], "LastName": "Murakami", "ForeName": "Shinji", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychiatry, Kawasaki Medical School, Kurashiki, 701-0192, Japan."}], "LastName": "Kitamura", "ForeName": "Naoya", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychiatry, Kawasaki Medical School, Kurashiki, 701-0192, Japan."}], "LastName": "Wani", "ForeName": "Kenta", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuropsychiatry, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, 700-8558, Japan."}], "LastName": "Matsumoto", "ForeName": "Yosuke", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Technology, Graduate School of Health Sciences, Okayama University, Okayama, 700-8558, Japan."}], "LastName": "Okamoto", "ForeName": "Motoi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychiatry, Kawasaki Medical School, Kurashiki, 701-0192, Japan."}], "LastName": "Ishihara", "ForeName": "Takeshi", "Initials": "T"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Pantelis C., Stuart G. W., Nelson H. E., Robbins T. W., Barnes T. R. Spatial Working Memory Deficits in Schizophrenia: Relationship With Tardive Dyskinesia and Negative Symptoms. The American Journal of Psychiatry. 2001;158(8):1276\u20131285. doi: 10.1176/appi.ajp.158.8.1276.", "ArticleIdList": ["10.1176/appi.ajp.158.8.1276", "11481163"]}, {"Citation": "Bora E., Yucel M., Pantelis C. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. The British Journal of Psychiatry. 2009;195(6):475\u2013482. doi: 10.1192/bjp.bp.108.055731.", "ArticleIdList": ["10.1192/bjp.bp.108.055731", "19949193"]}, {"Citation": "Keefe R. S. E., Bilder R. M., Davis S. M., et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Archives of General Psychiatry. 2007;64(6):633\u2013647. doi: 10.1001/archpsyc.64.6.633.", "ArticleIdList": ["10.1001/archpsyc.64.6.633", "17548746"]}, {"Citation": "Gao K., Kemp D. E., Ganocy S. J., Gajwani P., Xia G., Calabrese J. R. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. Journal of Clinical Psychopharmacology. 2008;28(2):203\u2013209. doi: 10.1097/jcp.0b013e318166c4d5.", "ArticleIdList": ["10.1097/jcp.0b013e318166c4d5", "PMC3489178", "18344731"]}, {"Citation": "Nasrallah H. A., Keshavan M. S., Benes F. M., et al. Proceedings and data from the Schizophrenia Summit: A critical appraisal to improve the management of schizophrenia. Journal of Clinical Psychiatry. 2009;70(1):4\u201346. doi: 10.4088/JCP.8157su1c.01.", "ArticleIdList": ["10.4088/JCP.8157su1c.01", "19292973"]}, {"Citation": "Sakurai H., Bies R. R., Stroup S. T., et al. Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data. Schizophrenia Bulletin. 2013;39(3):564\u2013574. doi: 10.1093/schbul/sbr189.", "ArticleIdList": ["10.1093/schbul/sbr189", "PMC3627781", "22290266"]}, {"Citation": "Lv X. N., Liu Z. J., Zhang H. J., Tzeng C. M. Aromatherapy and the central nerve system (CNS): therapeutic mechanism and its associated genes. Current Drug Targets. 2013;14(8):872\u2013879. doi: 10.2174/1389450111314080007.", "ArticleIdList": ["10.2174/1389450111314080007", "23531112"]}, {"Citation": "Zhang Y., Wu Y., Chen T., et al. Assessing the Metabolic Effects of Aromatherapy in Human Volunteers. Evidence-Based Complementary and Alternative Medicine. 2013;2013:9. doi: 10.1155/2013/356381.356381", "ArticleIdList": ["10.1155/2013/356381", "PMC3659644", "23737829"]}, {"Citation": "Lis-Balchin M. Essential oils and 'aromatherapy': their modern role in healing. Journal of the Royal Society of Health. 1997;117(5):324\u2013329. doi: 10.1177/146642409711700511.", "ArticleIdList": ["10.1177/146642409711700511", "9519666"]}, {"Citation": "De Sousa D. P., De Almeida Soares Hocayen P., Andrade L. N., Andreatini R. A. A systematic review of the anxiolytic-like effects of essential oils in animal models. Molecules. 2015;20(10):18620\u201318660. doi: 10.3390/molecules201018620.", "ArticleIdList": ["10.3390/molecules201018620", "PMC6332383", "26473822"]}, {"Citation": "Simonsen J., Ross W. C. The Triterpenes and Their Derivative S Hydroxy Acids, Hydroxy Lactones, Hydroxyaldehydo a Hardcover. 2nd. Cambridge; 1957."}, {"Citation": "Pereira Limberger R., Mendes Aleixo A., Fett-Neto A. G., T. Henriques A. Bioconversion of (+)- and (-)-alpha-pinene to (+)- and (-)-verbenone by plant cell cultures of Psychotria brachyceras and Rauvolfia sellowii. Electronic Journal of Biotechnology. 2007;10(4):0\u20130. doi: 10.2225/vol10-issue4-fulltext-8.", "ArticleIdList": ["10.2225/vol10-issue4-fulltext-8"]}, {"Citation": "Da Silva A. C. R., Lopes P. M., De Azevedo M. M. B., Costa D. C. M., Alviano C. S., Alviano D. S. Biological activities of \u03b1-pinene and \u03b2-pinene enantiomers. Molecules. 2012;17(6):6305\u20136316. doi: 10.3390/molecules17066317.", "ArticleIdList": ["10.3390/molecules17066317", "PMC6268778", "22634841"]}, {"Citation": "U.S. Food and Drug Administration. 2018."}, {"Citation": "Falk A., Gullstrand E., Wigaeus-Hjelm E. Liquid/air partition coefficients of four terpenes. British Journal of Industrial Medicine. 1990;47(1):62\u201364.", "ArticleIdList": ["PMC1035097", "2310709"]}, {"Citation": "Falk A. A., Hagberg M. T., Lof A. E., Wigaeus-Hjelm E. M., Wang Z. P. Uptake, distribution and elimination of alpha-pinene in man after exposure by inhalation. Scandinavian Journal of Work, Environment & Health. 1990;16(5):372\u2013378. doi: 10.5271/sjweh.1771.", "ArticleIdList": ["10.5271/sjweh.1771", "2255878"]}, {"Citation": "Mercier B., Prost J., Prost M. The essential oil of turpentine and its major volatile fraction (\u03b1- and \u03b2-pinenes): A review. International Journal of Occupational Medicine and Environmental Health. 2009;22(4):331\u2013342. doi: 10.2478/v10001-009-0032-5.", "ArticleIdList": ["10.2478/v10001-009-0032-5", "20197260"]}, {"Citation": "Martin S., Padilla E., Ocete M., Galvez J., Jim\u00e9nez J., Zarzuelo A. Anti-Inflammatory Activity of the Essential Oil of Bupleurum fruticescens. Planta Medica. 1993;59(06):533\u2013536. doi: 10.1055/s-2006-959755.", "ArticleIdList": ["10.1055/s-2006-959755", "8302953"]}, {"Citation": "Zhou J. Y., Tang F. D., Mao G. G., Bian R. L. Effect of alpha-pinene on nuclear translocation of NF-kappa B in THP-1 cells. Acta Pharmacologica Sinica. 2004;25(4):480\u2013484.", "ArticleIdList": ["15066217"]}, {"Citation": "Ahmad A., Husain A., Mujeeb M., et al. A review on therapeutic potential of Nigella sativa: a miracle herb. Asian Pacific Journal of Tropical Biomedicine. 2013;3(5):337\u2013352. doi: 10.1016/S2221-1691(13)60075-1.", "ArticleIdList": ["10.1016/S2221-1691(13)60075-1", "PMC3642442", "23646296"]}, {"Citation": "Consroe P., Martin A., Singh V. Antiepileptic potential of cannabidiol analogs. The Journal of Clinical Pharmacology. 1981;21(S1):428S\u2013436S. doi: 10.1002/j.1552-4604.1981.tb02623.x.", "ArticleIdList": ["10.1002/j.1552-4604.1981.tb02623.x", "7298873"]}, {"Citation": "Singh H. P., Batish D. R., Kaur S., Arora K., Kohli R. K. \u03b1-Pinene inhibits growth and induces oxidative stress in roots. Annals of Botany. 2006;98(6):1261\u20131269. doi: 10.1093/aob/mcl213.", "ArticleIdList": ["10.1093/aob/mcl213", "PMC2803591", "17028297"]}, {"Citation": "Eftekhar F., Yousefzadi M., Borhani K. Antibacterial activity of the essential oil from Ferula gummosa seed. Fitoterapia. 2004;75(7-8):758\u2013759. doi: 10.1016/j.fitote.2004.09.004.", "ArticleIdList": ["10.1016/j.fitote.2004.09.004", "15567258"]}, {"Citation": "Him A., Ozbek H., Turel I., Oner A. C. Antinociceptive activity of alpha-pinene and fenchone. Pharmacologyonline. 2008;3:363\u2013369."}, {"Citation": "Satou T., Kasuya H., Maeda K., Koike K. Daily Inhalation of \u03b1-Pinene in Mice: Effects on Behavior and Organ Accumulation. Phytotherapy Research. 2014;28(9):1284\u20131287. doi: 10.1002/ptr.5105.", "ArticleIdList": ["10.1002/ptr.5105", "25340185"]}, {"Citation": "Yamaoka S. Effects of Plant-derived Odors on Sleep-Wakefulness and Circadian Rhythmicity in Rats. Chemical Senses. 2005;30(Supplement 1):i264\u2013i265. doi: 10.1093/chemse/bjh216.", "ArticleIdList": ["10.1093/chemse/bjh216", "15738148"]}, {"Citation": "Okamura N., Hashimoto K., Shimizu E., Kumakiri C., Komatsu N., Iyo M. Adenosine A1 Receptor Agonists Block the Neuropathological Changes in Rat Retrosplenial Cortex after Administration of the NMDA Receptor Antagonist Dizocilpine. Neuropsychopharmacology. 2004;29(3):544\u2013550. doi: 10.1038/sj.npp.1300351.", "ArticleIdList": ["10.1038/sj.npp.1300351", "14603270"]}, {"Citation": "Xi D., Zhang W., Wang H., Stradtman G. G., Gao W. Dizocilpine (MK-801) induces distinct changes of N-methyl-d-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex. The International Journal of Neuropsychopharmacology. 2009;12(10):1395\u20131408. doi: 10.1017/S146114570900042X.", "ArticleIdList": ["10.1017/S146114570900042X", "PMC2859425", "19435549"]}, {"Citation": "Svoboda J., Stankova A., Entlerova M., Stuchlik A. Acute administration of MK-801 in an animal model of psychosis in rats interferes with cognitively demanding forms of behavioral flexibility on a rotating arena. Frontiers in Behavioral Neuroscience. 2015;9", "ArticleIdList": ["PMC4381641", "25883558"]}, {"Citation": "Murueta-Goyena A. L., Odrioizola A. B., Gargiulo P. A., S\u00e1nchez J. V. L. Neuropathological background of mk-801 for inducing murine model of schizophrenia. Psychiatry and Neuroscience Update. 2017;2:337\u2013354."}, {"Citation": "Behrens M. M., Ali S. S., Dao D. N., et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science. 2007;318(5856):1645\u20131647. doi: 10.1126/science.1148045.", "ArticleIdList": ["10.1126/science.1148045", "18063801"]}, {"Citation": "Braun I., Genius J., Grunze H., Bender A., M\u00f6ller H., Rujescu D. Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism. Schizophrenia Research. 2007;97(1-3):254\u2013263. doi: 10.1016/j.schres.2007.05.005.", "ArticleIdList": ["10.1016/j.schres.2007.05.005", "17601703"]}, {"Citation": "Gilmour G., Dix S., Fellini L., et al. NMDA receptors, cognition and schizophrenia\u2014testing the validity of the NMDA receptor hypofunction hypothesis. Neuropharmacology. 2012;62(3):1401\u20131412. doi: 10.1016/j.neuropharm.2011.03.015.", "ArticleIdList": ["10.1016/j.neuropharm.2011.03.015", "21420987"]}, {"Citation": "Jadi M. P., Behrens M. M., Sejnowski T. J. Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia. Biological Psychiatry. 2016;79(9):716\u2013726. doi: 10.1016/j.biopsych.2015.07.005.", "ArticleIdList": ["10.1016/j.biopsych.2015.07.005", "PMC4720598", "26281716"]}, {"Citation": "Dauvermann M. R., Lee G., Dawson N. Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research. British Journal of Pharmacology. 2017;174(19):3136\u20133160. doi: 10.1111/bph.13919.", "ArticleIdList": ["10.1111/bph.13919", "PMC5595770", "28626937"]}, {"Citation": "Javitt D. C. Glutamate as a therapeutic target in psychiatric disorders. Molecular Psychiatry. 2004;9(11):984\u2013997. doi: 10.1038/sj.mp.4001551.", "ArticleIdList": ["10.1038/sj.mp.4001551", "15278097"]}, {"Citation": "Hashimoto K., Okamura N., Shimizu E., Iyo M. Glutamate Hypothesis of Schizophrenia and Approach for Possible Therapeutic Drugs. Current Medicinal Chemistry-Central Nervous System Agents. 2004;4(2):147\u2013154. doi: 10.2174/1568015043357011.", "ArticleIdList": ["10.2174/1568015043357011"]}, {"Citation": "Coyle J. T. Substance use disorders and schizophrenia: A question of shared glutamatergic mechanisms. Neurotoxicity Research. 2006;10(3-4):221\u2013233. doi: 10.1007/BF03033359.", "ArticleIdList": ["10.1007/BF03033359", "17197372"]}, {"Citation": "Conn P. J., Tamminga C., Schoepp D. D., Lindsley C. Schizophrenia: Moving Beyond Monoamine Antagonists. Molecular Interventions. 2008;8(2):99\u2013107. doi: 10.1124/mi.8.2.7.", "ArticleIdList": ["10.1124/mi.8.2.7", "18403654"]}, {"Citation": "Lisman J. E., Coyle J. T., Green R. W., et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends in Neurosciences. 2008;31(5):234\u2013242. doi: 10.1016/j.tins.2008.02.005.", "ArticleIdList": ["10.1016/j.tins.2008.02.005", "PMC2680493", "18395805"]}, {"Citation": "Jeon S. J., Kim E., Lee J. S., et al. Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenia-like behaviors in mice. Neuropharmacology. 2017;126:168\u2013178. doi: 10.1016/j.neuropharm.2017.09.014.", "ArticleIdList": ["10.1016/j.neuropharm.2017.09.014", "28899728"]}, {"Citation": "Enomoto T., Ishibashi T., Tokuda K., Ishiyama T., Toma S., Ito A. Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats. Behavioural Brain Research. 2008;186(2):197\u2013207. doi: 10.1016/j.bbr.2007.08.012.", "ArticleIdList": ["10.1016/j.bbr.2007.08.012", "17881065"]}, {"Citation": "Bubser M., Bridges T. M., Dencker D., et al. Selective Activation of M 4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents. ACS Chemical Neuroscience. 2014;5(10):920\u2013942. doi: 10.1021/cn500128b.", "ArticleIdList": ["10.1021/cn500128b", "PMC4324418", "25137629"]}, {"Citation": "Park S. J., Lee Y., Oh H. K., et al. Oleanolic acid attenuates MK-801-induced schizophrenia-like behaviors in mice. Neuropharmacology. 2014;86:49\u201356. doi: 10.1016/j.neuropharm.2014.06.025.", "ArticleIdList": ["10.1016/j.neuropharm.2014.06.025", "24997455"]}, {"Citation": "O'Neill M. F., Hicks C. A., Shaw G., Parameswaran T., Cardwell G. P., O'Neill M. J. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine. The Journal of Pharmacology and Experimental Therapeutics. 1998;287(3):839\u2013846.", "ArticleIdList": ["9864262"]}, {"Citation": "Gray L., van den Buuse M., Scarr E., Dean B., Hannan A. J. Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-d-aspartic acid receptor up-regulation. The International Journal of Neuropsychopharmacology. 2009;12(01):45\u201360. doi: 10.1017/S1461145708009085.", "ArticleIdList": ["10.1017/S1461145708009085", "18593507"]}, {"Citation": "Bygrave A. M., Masiulis S., Nicholson E., et al. Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801. Translational Psychiatry. 2016;6(4):e778\u2013e778. doi: 10.1038/tp.2016.44.", "ArticleIdList": ["10.1038/tp.2016.44", "PMC4872402", "27070406"]}, {"Citation": "Ueno H., Shimada A., Suemitsu S., et al. Anti-depressive-like effect of 2-phenylethanol inhalation in mice. Biomedicine & Pharmacotherapy. 2019;111:1499\u20131506. doi: 10.1016/j.biopha.2018.10.073.", "ArticleIdList": ["10.1016/j.biopha.2018.10.073", "30415864"]}, {"Citation": "Koshimizu H., Takao K., Matozaki T., Ohnishi H., Miyakawa T., Tang Y. Comprehensive Behavioral Analysis of Cluster of Differentiation 47 Knockout Mice. PLoS ONE. 2014;9(2) doi: 10.1371/journal.pone.0089584.e89584", "ArticleIdList": ["10.1371/journal.pone.0089584", "PMC3933641", "24586890"]}, {"Citation": "Rompala G. R., Zsiros V., Zhang S., Kolata S. M., Nakazawa K., Yoshikawa T. Contribution of NMDA Receptor Hypofunction in Prefrontal and Cortical Excitatory Neurons to Schizophrenia-Like Phenotypes. PLoS ONE. 2013;8(4) doi: 10.1371/journal.pone.0061278.e61278", "ArticleIdList": ["10.1371/journal.pone.0061278", "PMC3628715", "23613827"]}, {"Citation": "Matsuda I., Shoji H., Yamasaki N., Miyakawa T., Aiba A. Comprehensive behavioral phenotyping of a new Semaphorin 3 F mutant mouse. Molecular Brain. 2016;9(1, article no. 15) doi: 10.1186/s13041-016-0196-4.", "ArticleIdList": ["10.1186/s13041-016-0196-4", "PMC4746810", "26856818"]}, {"Citation": "Bansal P. K., Deshmukh R. Animal Models of Neurological Disorders. Principle and Working Procedure for Animal Models of Neurological Disorders. Springer; 2017."}, {"Citation": "Okonogi T., Nakayama R., Sasaki T., Ikegaya Y. Characterization of peripheral activity states and cortical local field potentials of mice in an elevated plus maze test. Frontiers in Behavioral Neuroscience. 2018;12", "ArticleIdList": ["PMC5891585", "29666572"]}, {"Citation": "Wolf A., Bauer B., Abner E. L., Ashkenazy-Frolinger T., Hartz A. M. S. A comprehensive behavioral test battery to assess learning and memory in 129S6/Tg2576 mice. PLoS ONE. 2016;11(1) doi: 10.1371/journal.pone.0147733.e0147733", "ArticleIdList": ["10.1371/journal.pone.0147733", "PMC4726499", "26808326"]}, {"Citation": "Vogel H. Drug Discovery and Evaluation: Pharmacological Assays. Springer; 2007."}, {"Citation": "Nakatani J., Tamada K., Hatanaka F., et al. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell. 2009;137(7):1235\u20131246. doi: 10.1016/j.cell.2009.04.024.", "ArticleIdList": ["10.1016/j.cell.2009.04.024", "PMC3710970", "19563756"]}, {"Citation": "Chartoff E. H., Heusner C. L., Palmiter R. D. Dopamine is not Required for the Hyperlocomotor Response to NMDA Receptor Antagonists. Neuropsychopharmacology. 2005;30(7):1324\u20131333. doi: 10.1038/sj.npp.1300678.", "ArticleIdList": ["10.1038/sj.npp.1300678", "15688082"]}, {"Citation": "Belzung C. Measuring exploratory behavior. In: Crusio W. E., Gerlai R. T., editors. Handbook of molecular genetics techniques for brain and behavior research (techniques in the behavioral and neural sciences) Vol. 13. Elsevier; 1999. pp. 738\u2013749. (Techniques in the Behavioral and Neural Sciences).", "ArticleIdList": ["10.1016/S0921-0709(99)80057-1"]}, {"Citation": "Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. European Journal of Pharmacology. 2003;463(1\u20133):3\u201333. doi: 10.1016/S0014-2999(03)01272-X.", "ArticleIdList": ["10.1016/S0014-2999(03)01272-X", "12600700"]}, {"Citation": "Zamyad M., Abasnejad M., Esmaeili-Mahani S., Mostafavi A. Alpha-Pinene as the Main Component of Ducrosia anethifolia (Boiss) Essential Oil is Responsible for its Effect on Locomotor Activity in Rats. Avicenna Journal of Neuro Psych Physiology. 2016;3(2) doi: 10.17795/ajnpp-38787.", "ArticleIdList": ["10.17795/ajnpp-38787"]}, {"Citation": "Dai H., Carey R. J. The NMDA antagonist MK-801 can impair attention to exteroceptive stimuli. Behavioural Brain Research. 1994;62(2):149\u2013156. doi: 10.1016/0166-4328(94)90022-1.", "ArticleIdList": ["10.1016/0166-4328(94)90022-1", "7945965"]}, {"Citation": "Plaznik A., Palejko W., Nazar M., Jessa M. Effects of antagonists at the NMDA receptor complex in two models of anxiety. European Neuropsychopharmacology. 1994;4(4):503\u2013512. doi: 10.1016/0924-977X(94)90299-2.", "ArticleIdList": ["10.1016/0924-977X(94)90299-2", "7894261"]}, {"Citation": "Lee G. Y., Lee C., Park G. H., Jang J. H. Amelioration of Scopolamine-Induced Learning and Memory Impairment by \u03b1-Pinene in C57BL/6 Mice. Evidence-Based Complementary and Alternative Medicine. 2017;2017:9. doi: 10.1155/2017/4926815.4926815", "ArticleIdList": ["10.1155/2017/4926815", "PMC5687139", "29234406"]}, {"Citation": "Sharma A. C., Kulkarni S. K. MK-801 produces antianxiety effect in elevated plus-maze in mice. Drug Development Research. 1991;22(3):251\u2013258. doi: 10.1002/ddr.430220307.", "ArticleIdList": ["10.1002/ddr.430220307"]}, {"Citation": "Bertoglio L. J., Carobrez A. P. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats. Psychopharmacology. 2003;170(4):335\u2013342. doi: 10.1007/s00213-003-1558-z.", "ArticleIdList": ["10.1007/s00213-003-1558-z", "13680083"]}, {"Citation": "Choy K. H. C., de Visser Y., Nichols N. R., van den Buuse M. Combined neonatal stress and young-adult glucocorticoid stimulation in rats reduce BDNF expression in hippocampus: effects on learning and memory. Hippocampus. 2008;18(7):655\u2013667. doi: 10.1002/hipo.20425.", "ArticleIdList": ["10.1002/hipo.20425", "18398848"]}, {"Citation": "Shipton O. A., El-Gaby M., Apergis-Schoute J., et al. Left\u2013right dissociation of hippocampal memory processes in mice. Proceedings of the National Acadamy of Sciences of the United States of America. 2014;111(42):15238\u201315243. doi: 10.1073/pnas.1405648111.", "ArticleIdList": ["10.1073/pnas.1405648111", "PMC4210314", "25246561"]}, {"Citation": "Mihara T., Mihara K., Yarimizu J., et al. Pharmacological Characterization of a Novel, Potent Adenosine A1 and A2A Receptor Dual Antagonist, 5-[5-Amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in Models of Parkinson's Disease and Cognition. The Journal of Pharmacology and Experimental Therapeutics. 2007;323(2):708\u2013719. doi: 10.1124/jpet.107.121962.", "ArticleIdList": ["10.1124/jpet.107.121962", "17684118"]}, {"Citation": "Okuyama S., Fukata T., Nishigawa Y., et al. Citrus flavonoid improves MK-801-induced locomotive hyperactivity: Possible relevance to schizophrenia. Journal of Functional Foods. 2013;5(4):2002\u20132006. doi: 10.1016/j.jff.2013.07.016.", "ArticleIdList": ["10.1016/j.jff.2013.07.016"]}, {"Citation": "Hasegawa Y., Inoue T., Kawaminami S., Fujita M. Effects of scallop shell extract on scopolamine-induced memory impairment and MK801-induced locomotor activity. Asian Pacific Journal of Tropical Medicine. 2016;9(7):662\u2013667. doi: 10.1016/j.apjtm.2016.05.019.", "ArticleIdList": ["10.1016/j.apjtm.2016.05.019", "27393094"]}, {"Citation": "Petrenko A. B., Yamakura T., Baba H., Shimoji K. The Role of N-Methyl-d-Aspartate (NMDA) Receptors in Pain: A Review. Anesthesia & Analgesia. 2003:1108\u20131116. doi: 10.1213/01.ANE.0000081061.12235.55.", "ArticleIdList": ["10.1213/01.ANE.0000081061.12235.55", "14500166"]}, {"Citation": "Willert R. P., Woolf C. J., Hobson A. R., Delaney C., Thompson D. G., Aziz Q. The Development and Maintenance of Human Visceral Pain Hypersensitivity Is Dependent on the N-Methyl-D-Aspartate Receptor. Gastroenterology. 2004;126(3):683\u2013692. doi: 10.1053/j.gastro.2003.11.047.", "ArticleIdList": ["10.1053/j.gastro.2003.11.047", "14988822"]}, {"Citation": "McRoberts J., Ennes H., Marviz\u00f3n J., Fanselow M., Mayer E., Vissel B. Selective knockdown of NMDA receptors in primary afferent neurons decreases pain during phase 2 of the formalin test. Neuroscience. 2011;172:474\u2013482. doi: 10.1016/j.neuroscience.2010.10.045.", "ArticleIdList": ["10.1016/j.neuroscience.2010.10.045", "PMC3010451", "20974228"]}, {"Citation": "Meymandi M. S., Keyhanfar F., Sepehri G. R., Heravi G., Yazdanpanah O. The contribution of NMDA receptors in antinociceptive effect of pregabalin: Comparison of two models of pain assessment. Anesthesiology and Pain Medicine. 2017;7(3)e14602", "ArticleIdList": ["PMC5559703", "28824867"]}, {"Citation": "Paul I. A., Skolnick P. Glutamate and Depression. Annals of the New York Academy of Sciences. 2003;1003(1):250\u2013272. doi: 10.1196/annals.1300.016.", "ArticleIdList": ["10.1196/annals.1300.016", "14684451"]}, {"Citation": "Mitani H., Shirayama Y., Yamada T., Maeda K., Ashby C. R., Kawahara R. Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2006;30(6):1155\u20131158. doi: 10.1016/j.pnpbp.2006.03.036.", "ArticleIdList": ["10.1016/j.pnpbp.2006.03.036", "16707201"]}, {"Citation": "Mantovani M., P\u00e9rtile R., Calixto J. B., Santos A. R. S., Rodrigues A. L. S. Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway. Neuroscience Letters. 2003;343(1):1\u20134. doi: 10.1016/s0304-3940(03)00306-9.", "ArticleIdList": ["10.1016/s0304-3940(03)00306-9", "12749983"]}, {"Citation": "Sanacora G., Zarate C. A., Krystal J. H., Manji H. K. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nature Reviews Drug Discovery. 2008;7(5):426\u2013437. doi: 10.1038/nrd2462.", "ArticleIdList": ["10.1038/nrd2462", "PMC2715836", "18425072"]}, {"Citation": "Kong Y., Wang T., Wang R., et al. Inhalation of Roman chamomile essential oil attenuates depressive-like behaviors in Wistar Kyoto rats. Science China Life Sciences. 2017;60(6):647\u2013655. doi: 10.1007/s11427-016-9034-8.", "ArticleIdList": ["10.1007/s11427-016-9034-8", "28527112"]}, {"Citation": "Aoshima H., Hamamoto K. Potentiation of GABAA receptors expressed in Xenopus oocytes by perfume and phytoncid. Bioscience, Biotechnology, and Biochemistry. 1999;63(4):743\u2013748. doi: 10.1271/bbb.63.743.", "ArticleIdList": ["10.1271/bbb.63.743", "10361687"]}, {"Citation": "Yang H., Woo J., Pae A. N., et al. \u03b1-pinene, a major constituent of pine tree oils, enhances non-rapid eye movement sleep in mice through GABAA-benzodiazepine receptors. Molecular Pharmacology. 2016;90(5):530\u2013539. doi: 10.1124/mol.116.105080.", "ArticleIdList": ["10.1124/mol.116.105080", "27573669"]}, {"Citation": "Kasture V. S., Chopde C. T., Deshmukh V. K. Anticonvulsive activity of Albizzia lebbeck, Hibiscus rosa sinesis and Butea monosperma in experimental animals. Journal of Ethnopharmacology. 2000;71(1-2):65\u201375. doi: 10.1016/S0378-8741(99)00192-0.", "ArticleIdList": ["10.1016/S0378-8741(99)00192-0", "10904147"]}, {"Citation": "Brunton L., Lazo J., Parker K. Goodman And Gilman's The Pharmacological Basis of Therapeutics. 11th. McGraw-Hill Education / Medical; 2006."}, {"Citation": "Guimar\u00e3es A. G., Quintans J. S. S., Quintans-J\u00fanior L. J. Monoterpenes with analgesic activity\u2014a systematic review. Phytotherapy Research. 2013;27(1):1\u201315. doi: 10.1002/ptr.4686.", "ArticleIdList": ["10.1002/ptr.4686", "23296806"]}, {"Citation": "Scheuplein R., Blank I., Brauner G., Macfarlane D. J. Percutaneous Absorption of Steroids\u2217. Journal of Investigative Dermatology. 1969;52(1):63\u201370. doi: 10.1038/jid.1969.9.", "ArticleIdList": ["10.1038/jid.1969.9", "5761930"]}, {"Citation": "Fisher A. N., Brown K., Davis S. S., Parr G. D., Smith D. A. The effect of molecular size on the nasal absorption of water\u2010soluble compounds in the albino rat. Journal of Pharmacy and Pharmacology. 1987;39(5):357\u2013362. doi: 10.1111/j.2042-7158.1987.tb03398.x.", "ArticleIdList": ["10.1111/j.2042-7158.1987.tb03398.x", "2441020"]}]}], "History": [{"Year": "2019", "Month": "3", "Day": "21"}, {"Year": "2019", "Month": "6", "Day": "11"}, {"Year": "2019", "Month": "7", "Day": "4"}, {"Year": "2019", "Month": "8", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "31", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "7", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["31467573", "PMC6699265", "10.1155/2019/2745453"]}}]}